Welcome to the homepage of the Institute of Cardiovascular Regeneration. Main focus of our Institute is the research and development of potential therapeutics for the treatment of cardiovascular diseases. The Institute elucidates the basic mechanisms underlying cardiovascular disease and vessel growth with the aim to develop new cellular and pharmacological therapies for improving the treatment of cardiovascular disease. Ongoing research focuses on epigenetic mechanisms that control cardiovascular repair, specifically the function of histone modifying enzymes and non-coding RNAs. Our lab is an international and interdisciplinary team consisting of independent group leaders as well as Postdocs with a medical and basic science background, PhDs and MD students and research associates.
NEWS: Research
COVID-19: Heart patients are particularly affected by SARS-CoV-2 infection
ACE2 is a protein on the surface of cells and serves as the entry gate …
Transcriptional heterogeneity of fibroblasts is a hallmark
of the aging heart. New publication in JCI Insight…
NEWS: Awards & Grants
Stefanie Dimmeler among Highly Cited Researchers 2023
Prof. Dr. Stefanie Dimmeler / Director of the Institute of Cardiovascular Regeneration at Goethe University …
Julian Wagner receives ESC Award
Congratulations to Julian Wagner for receiving an ESC Award in recognition of outstanding scientific in …
HERZBLUT research group receives DFG funding
ICR members Stefanie Dimmeler, Andreas Zeiher, Wesley Abplanalp, Sebstian Cremer and Jaya Krishnan receive DFG funding …